Irbesartan Tablet
Product Images NDC 65162-286

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Irbesartan (NDC 65162-286). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Irbesartan Tablets 1)

Chemical structure of Irbesartan, showing its molecular framework including a biphenyl group, a tetrazole ring, and other characteristic functional groups.*

FDA Label Image

Figure 1 (Irbesartan Tablets 2)

A line and scatter plot chart depicting the placebo-subtracted reduction in trough SeSBP (systolic blood pressure) against Irbesartan dose in mg/day, ranging from 0 to 900 mg/day on the x-axis and showing mmHg changes on the y-axis from -4 to 12. The chart illustrates an integrated analysis with a curve showing increasing reduction in SeSBP with dose, leveling off near the higher doses.*

FDA Label Image

Figure 2 (Irbesartan Tablets 3)

A scatter plot chart showing the relationship between Irbesartan dose (mg/day) on the x-axis from 0 to 900 and mmHg reduction on the y-axis from -2 to 8. The data points indicate a trend of increasing reduction with dose, leveling off at higher doses, illustrating the placebo-subtracted reduction in trough SeDBP.*

FDA Label Image

Figure 3 (Irbesartan Tablets 4)

A line graph showing cumulative event rates over months of follow-up for Irbesartan, Amlodipine, and Placebo groups. The chart includes relative risk (RR) and p-values comparing Irbesartan to Placebo and Amlodipine, depicting event incidence trends over a 60-month period.*

FDA Label Image

75 (Irbesartan Tablets 5)

Label for Irbesartan Tablets, USP 75 mg oral tablets by Amneal Pharmaceuticals LLC. The label indicates each tablet contains 75 mg of irbesartan and includes storage instructions. The package contains 30 tablets. Manufacturer: Amneal Pharmaceuticals Pvt. Ltd., India. Distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ.*

FDA Label Image

150 (Irbesartan Tablets 6)

Label for Irbesartan Tablets, USP, 150 mg strength. The label indicates a package of 30 tablets used for oral administration. Manufactured by Amneal Pharmaceuticals Pvt. Ltd. in India and distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ. The label includes storage instructions and a barcode.*

FDA Label Image

300 (Irbesartan Tablets 7)

Label for Irbesartan Tablets, USP 300 mg oral tablets, containing 30 tablets per bottle. The label shows the product name, strength, and dosage form, stating each tablet contains 300 mg of irbesartan. It is manufactured by Amneal Pharmaceuticals Pvt. Ltd. in India and distributed by Amneal Pharmaceuticals LLC in New Jersey, USA. Storage temperature instructions and a barcode are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.